Skip to content

Clinical trials

Lymphoproliferative Disorders trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Country / region: Czechia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20141
20151
20172
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acerta Pharma BV1
Amgen1
Ariad Pharmaceuticals1
Cellectar Biosciences, Inc.1
Curis, Inc.1
European Association of Urology Research Foundation1
Millennium Pharmaceuticals, Inc.1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders8
Immunoproliferative Disorders6
Neoplasms6
Lymphatic Diseases5
Lymphoma5
Hematologic Diseases4
Immune System Diseases4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Non-Hodgkin4
Recurrence3

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.